Sarepta Therapeutics, Inc. SRPT Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s net margin?
- Sarepta Therapeutics, Inc. (SRPT) reported net margin of 4.6% in Q3 2024.
- How has Sarepta Therapeutics, Inc.'s net margin changed year-over-year?
- Sarepta Therapeutics, Inc.'s net margin increased by 107.4% year-over-year, from -62.5% to 4.6%.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s net margin?
- Over 3 years (2020 to 2023), Sarepta Therapeutics, Inc.'s net margin has grown at a -23.0% compound annual growth rate (CAGR), from -102.6% to -46.8%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.